| Name | (2R)-2-amino-5-phosphonopentanoic acid |
|---|---|
| Synonyms |
D-2-AMINO-5-PHOSPHONOPENTANOIC ACID
(R)-5-Phosphono-2-aminovaleric acid D(-)-2-Amino-5-phosphonovaleric acid hydrate D-Norvaline, 5-phosphono D(-)-AP-5, D(-)-APV, D-2-Amino-5-phosphonovaleric acid D-Norvaline,5-phosphono D-(-)-2-AMINO-5-PHOSPHONOPENTANOIC ACID D-AP5 ,E1246 D-AP5 (mM/ml), NMDA glutamate site antagonist D-AP5 (-)-2-Amino-5-phosphonovaleric acid D(-)-APV Anti-EIF4G2, N-Terminal antibody produced in rabbit D ()-2-Amino-5-phosphonopentanoic acid (R)-AP-5 5-Phosphono-D-norvaline 5-PHOSPHONO-DL-NORVALINE Emasol L 10 D(-)-2-Amino-5-phosphonovaleric acid (D-AP5) D-AP5, NMDA glutamate site antagonist UNII:39PJ29YY8Z D-AP5, 10 mM in DMSO D-2-Amino-5-phosphonovaleric acid D-2-Amino-5-phosphopentanoic acid (2R)-2-Amino-5-phosphonovaleric acid D-(–)-2-Amino-5-phosphonopentanoic Acid - - Calbiochem IF4G2 (R)-2-amino-5-phosphonopentanoic acid Emasol L-10 D-APV|||D-2-Amino-5-phosphonovaleric acid D-(-)-2-AMINO-5-PHOSPHONOVALERIC ACID (R)-2-Amino-5-phosphonovaleric acid D(-)-2-Amino-5-phosphonovaleric acid hydrate, ( ee) D-APV D(-)-2-AMINO-5-PHOSPHONOVALERIC ACID (D-AP5);5-PHOSPHONO-D-NORVALINE (2R)-2-aMMonio-5-phosphonatopentanoate [3H]-D(-)-2-Amino-5-phosphonopentanoic acid Death associated protein 5 5-Phosphononorvaline Eukyotic translation initiation factor 4 γ 2 D-AP5 (Synonyms: D-APV Emasol L10 D-(-)-2-AMINO-5-PHOSPHONOPENTANOIC ACID (D-AP5) EIF4G2 D(-)-2-AMINO-5-PHOSPHONOPENTANOIC AC D(-)-2-Amino-5-phosphonopentanoic acid |
| Description | D-AP5 is a NMDA receptor antagonist. |
|---|---|
| Related Catalog | |
| Target |
NMDA[1] |
| In Vivo | D-AP5 is a NMDA receptor antagonist. Chronic intraventricular infusion of D-AP5 causes a parallel dose-dependent impairment of spatial learning and long-term potentiation (LTP) in vivo. Intracerebral concentrations of D-AP5 fail to induce any measurable sensorimotor disturbance when spatial learning is prevented[1]. D-AP5 infusion is associated with a progressive reduction in swim speed over trials. D-AP5 causes sensorimotor disturbances in the spatial task, but these gradually worsened as the animals fail to learn. Rats treated with D-AP5 show a delay-dependent deficit in spatial memory in the delayed matching-to-place protocol for the water maze[2]. |
| Animal Admin | Male Lister hooded rats are used in this study. They are housed individually and have free access to food and water at all times except for 12 hr prior to surgery. Animals are implanted with 30 mM D-AP5 (N=6) and tested in the water maze[1]. |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 482.1±55.0 °C at 760 mmHg |
| Molecular Formula | C5H12NO5P |
| Molecular Weight | 197.126 |
| Flash Point | 245.4±31.5 °C |
| Exact Mass | 197.045303 |
| PSA | 130.66000 |
| LogP | -2.32 |
| Vapour Pressure | 0.0±2.6 mmHg at 25°C |
| Index of Refraction | 1.536 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
|---|---|
| Hazard Codes | Xi |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |